bioRxiv ScienceSearch

Biology subjects

Adam Auton

Publications and source records attributed to Adam Auton.

3 recordsLinked to original sources

False Negatives Are a Significant Feature of Next Generation Sequencing Callsets

Short-read, next-generation sequencing (NGS) is now broadly used to identify rare or de novo mutations in population samples and disease cohorts. However, NGS data is known to be error-prone and post-processing pipelines have primarily focused on the removal of spurious mutations or \"false positives\" in downstream genome datasets. Less attention has been paid to characterizing the fraction of missing mutations or \"false negatives\" (FN). We design a phylogeny-aware tool to determine false negatives [PhyloFaN] and describe how read coverage and reference bias affect the FN rate. Using thousand-fold coverage NGS data from both Illumina HiSeq and Complete Genomics platforms derived from the 1000 Genomes Project, we first characterize the false negative rate in human mtDNA genomes. The false negative rate for the publically available callsets is 17-20%, even for extremely high coverage haploid data. We demonstrate that high FN rates are not limited to mtDNA by comparing autosomal data from 28 publically available full genomes to intergenic Sanger sequenced regions for each individual. We examine both low-coverage Illumina and high-coverage Complete Genomics genomes. We show that the FN rate varies between [~]6%-18% and that false-positive rates are considerably lower (<3%). The FN rate is strongly dependent on calling pipeline parameters, as well as read coverage. Our results demonstrate that missing mutations are a significant feature of genomic datasets and imply additional fine-tuning of bioinformatics pipelines is needed. We provide a tool which can be used to quantify the FN rate for haploid genomic experiments, without additional generation of validation data.\n\nData depositionData and software are freely available on the Henn Lab website: https://ecoevo.stonybrook.edu/hennlab/data-software/\n\nSoftwareGITHUB via https://ecoevo.stonybrook.edu/hennlab/data-software/

Bioinformatics

A direct multi-generational estimate of the human mutation rate from autozygous segments seen in thousands of parentally related individuals

Heterozygous mutations within homozygous sequences descended from a recent common ancestor offer a way to ascertain de novo mutations (DNMs) across multiple generations. Using exome sequences from 3,222 British-Pakistani individuals with high parental relatedness, we estimate a mutation rate of 1. 45 {+/-} 0.05 x 10-8 per base pair per generation in autosomal coding sequence, with a corresponding noncrossover gene conversion rate of 8.75 {+/-} 0.05 x 10-6 per base pair per generation. This is at the lower end of exome mutation rates previously estimated in parent-offspring trios, suggesting that post-zygotic mutations contribute little to the human germline mutation rate. We found frequent recurrence of mutations at polymorphic CpG sites, and an increase in C to T mutations in a 5 CCG 3 [->] 5 CTG 3 context in the Pakistani population compared to Europeans, suggesting that mutational processes have evolved rapidly between human populations.

Genomics

MOSAIC EPIGENETIC DYSREGULATION OF ECTODERMAL CELLS IN AUTISM SPECTRUM DISORDER

DNA mutational events are increasingly being identified in autism spectrum disorder (ASD), but the potential additional role of dysregulation of the epigenome in the pathogenesis of the condition remains unclear. The epigenome is of interest as a possible mediator of environmental effects during development, encoding a cellular memory reflected by altered function of progeny cells. Advanced maternal age (AMA) is associated with an increased risk of having a child with ASD for reasons that are not understood. To explore whether AMA involves covert aneuploidy or epigenetic dysregulation leading to ASD in the offspring, we tested an homogeneous ectodermal cell type from 47 individuals with ASD compared with 48 typically developing (TD) controls born to mothers of [&ge;]35 years, using a quantitative genome-wide DNA methylation assay. We show that DNA methylation patterns are dysregulated in ectodermal cells in these individuals, having accounted for confounding effects due to subject age, sex and ancestral haplotype. We did not find mosaic aneuploidy or copy number variability to occur at differentially-methylated regions in these subjects. Of note, the loci with distinctive DNA methylation were found at genes expressed in the brain and encoding protein products significantly enriched for interactions with those produced by known ASD-causing genes, representing a perturbation by epigenomic dysregulation of the same networks compromised by DNA mutational mechanisms. The results indicate the presence of a mosaic subpopulation of epigenetically-dysregulated, ectodermally-derived cells in subjects with ASD. The epigenetic dysregulation observed in these ASD subjects born to older mothers may be associated with aging parental gametes, environmental influences during embryogenesis or could be the consequence of mutations of the chromatin regulatory genes increasingly implicated in ASD. The results indicate that epigenetic dysregulatory mechanisms may complement and interact with DNA mutations in the pathogenesis of the disorder.\n\nAUTHOR SUMMARYOlder mothers have a higher than expected risk of having a child with an autism spectrum disorder (ASD). The reason for this increased risk is unknown. The eggs of older mothers are more prone to abnormalities of chromosome numbers, suggesting this as one possible mechanism of the increased ASD risk. Age is also associated with a loss of control of epigenetic regulatory patterns that govern gene expression, indicating a second potential mechanism. To test both possibilities, we sampled cells from the same developmental origin as the brain, and performed genome-wide tests looking for unusual chromosome numbers and DNA methylation patterns. The studies were performed on individuals with ASD and typically developing controls, all born to mothers at least 35 years of age at the time of birth. We found the cells from individuals with ASD to have changes in DNA methylation at a number of loci, especially near genes encoding proteins known to interact with those already implicated in ASD. We conclude that epigenetic dysregulation occurring in gametes or early embryonic life may be one of the contributors to the development of ASD.

Genomics